Different manifestations of nervous system involvement by neurobrucellosis

Neurosciences

Volumn 13, Issue 3, 2008, Pages 283-287

  Karaoglan, Ilkay ^a   Namiduru, Mustafa ^a   Akcali, Aylin ^a   Cansel, Neslihan ^a  

^a GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; CEFTRIAXONE; COTRIMOXAZOLE; DOXYCYCLINE; PREDNISOLONE; RIFAMPICIN; STEROID;

ADULT; AGED; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM ISOLATION; BRUCELLA; BRUCELLOSIS; CENTRAL NERVOUS SYSTEM INFECTION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL FEATURE; DEMYELINATING DISEASE; DISEASE CLASSIFICATION; DISEASE DURATION; EARLY DIAGNOSIS; FEMALE; HUMAN; LABORATORY DIAGNOSIS; LABORATORY TEST; MALE; MENINGOENCEPHALITIS; MENTAL DISEASE; MORTALITY; MULTIPLE SCLEROSIS; MYELITIS; NEUROBRUCELLOSIS; NEUROLOGIC DISEASE; PHYSICAL EXAMINATION; PLEOCYTOSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; RADIODIAGNOSIS; RETROSPECTIVE STUDY; SEROLOGY; SYMPTOMATOLOGY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TURKEY (BIRD);

EID: 47749123807     PISSN: 13196138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Young EJ. Brucella species. In: Mandel GL, Bennet JE, Dolin R, editors. Mandel, Douglas and Bennett's Principles and Practice of Infectious Disease. 6th ed. New York (NY): Elsevier Churchill Livingstone; 2005. p. 2669-2674.
2. Sohn HA, Probert WS, Glasser CA, Gupta N, Bollen AW, Wong JD, et al. Human Neurobrucellosis with intracerebral granuloma caused by a marine mammal Brucella spp. Emerg Infect Dis 2003; 9: 485-488.
3. Gottuzu E, Carrilo C. Brucella. In: Gorbach SL, Bartlett JG, Blacklow NR, editors. Infectious disease. 3rd ed. Philadelphia (PA): Lippincott, Williams & Wilkins; 2004. p. 1717-1724.
4. Karaoglan I, Akcali A, Ozkur A, Namiduru M. Neurobrucellosis mimicking demyelinizating disorders. Ann Saudi Med 2008; 28: 148-149.
5. al Deeb SM, Yaqub BA, Sharif HS, Phadke JK. Neurobrucellosis: clinical characteristics, diagnosis and outcome. Neurology 1989; 39: 498-501.
6. Yetkin MA, Bulut C, Erdinç FS, Oral B, Tulek N. Evaluation of the clinical presentations in neurobrucellosis. Int J Infect Dis 2006; 10: 446-452.
7. Bodur H, Erbay A, Akinci E, Colpan A, Cevik MA, Balaban N. Neurobrucellosis in an endemic area of brucellosis. Scand J Infect Dis 2003; 35: 94-97.
8. Shakir RA, Al-Din AS, Araj GF, Lulu AR, Mousa AR, Saadah MA. Clinical categories of neurobrucellosis: a report 19 cases. Brain 1987; 110: 213-223.
9. Bashir R, Al-Kawi MZ, Harder EJ, Jinkins J. Nervous system brucellosis: diagnosis and treatment. Neurology 1985; 35: 1576-1581.
10. Kochar DK, Agarwal N, Jain N, Sharma BV, Rastogi A, Meena CB. Clinical profile of neurobrucellosis-A report on 12 cases from Bikaner (North-West India). J Assoc Physicians India 2000; 48: 376-380.
11. Samdani PG, Patil S. Neurobrucellosis:case reports. Indian Pediatrics 2003; 40: 565-568.
12. Yilmaz M, Ozaras R, Ozturk R, Mert A, Tabak F, Aktuglu Y. Epileptic seizure: an atypical presentation in an adolescent boy with neurobrucellosis. Scand J Infect Dis 2002; 34: 623-625.
13. McLean DR, Russell N, Khan MY. Neurobrucellosis: clinical and therapeutic feature. Clin Infec Dis 1992; 15: 582-590.
14. Kumandaş S, Elmas B, Üzüm K, Coşkun A, Findik M, Gür C, et al. Childhood neurobrucellosis: case report. T Klin Ped 2003; 12: 36-41.
15. Al-Sous MW, Bohlega S, Al-Kawi MZ, Alwatban J, McLean DR. Neurobrucellosis: clinical and neuroimaging correlation. AJNR Am J Neuroradiol 2004; 25: 395-401.
16. Eren S, Baram G, Ergönül Ö, Çelikbas A, Pazvantoglu O, Baykam N, et al. Cognitive and emotional changes in neurobrucellosis. J Infect 2006; 53: 184-189.
17. Abduljabbar MS. Adenosine deaminase concentration in cerebrospinal fluid during brucella meningitis. J Infect 1994; 29: 41-44.